Megan Weaver is Senior Vice President, Clinical Development Operations at Neurvati Neurosciences and GRIN Therapeutics, responsible for clinical operations, data management, medical writing, clinical site monitoring and GCP process optimization. In a career spanning 25 years, she brings significant operational and strategic development expertise in rare diseases, immunology, oncology and neurology spanning all phases of product development. Prior to Neurvati, she spent six years at Agios Pharmaceuticals where she led the oncology and rare clinical development operations organization and had responsibility for the clinical operations, medical writing, data management/systems, vendor outsourcing and process improvement functional areas. Prior to Agios, Megan spent almost 20 years at Biogen in roles of increasing responsibility in clinical operations and pharmaceutical operations/clinical drug supply.

She received her undergraduate degree in biology from Bowdoin College and her MPH focused in epidemiology and maternal and child health from Boston University.